Search Results - Michael Sweeney
- Showing 1 - 7 results of 7
-
1
-
2
Effect of various aromatic compounds with different functional groups on enzymatic hydrolysis of microcrystalline cellulose and alkaline pretreated wheat straw by Yufeng Yuan, Xinyu Guo, Bo Jiang, Wenjuan Wu, Tingwei Zhang, Michael Sweeney, Mehraj Ahmad, Yongcan Jin
Published in Journal of Bioresources and Bioproducts (2024-05-01)Get full text
Article -
3
Intramedullary use of an antibiotic synthetic bone filler in diabetics undergoing metatarsal amputation(s) by Thomas Poynter, DPM, Kaitlyn J. Loesel, DPM, Michael Sweeney, DPM, Alden Simmons, DPM, Brandon Kitchens, DPM, Timothy Ford, DPM, Nicholas Laco, DPM
Published in Foot & Ankle Surgery: Techniques, Reports & Cases (2025-01-01)Get full text
Article -
4
Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells by Christopher D. Sarsons, Dean Gilham, Laura M. Tsujikawa, Sylwia Wasiak, Li Fu, Brooke D. Rakai, Stephanie C. Stotz, Agostina Carestia, Michael Sweeney, Ewelina Kulikowski
Published in Biomedicines (2023-09-01)Get full text
Article -
5
Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment by Dean Gilham, Sylwia Wasiak, Brooke D. Rakai, Li Fu, Laura M. Tsujikawa, Christopher D. Sarsons, Agostina Carestia, Kenneth Lebioda, Jan O. Johansson, Michael Sweeney, Kamyar Kalantar-Zadeh, Ewelina Kulikowski
Published in Biomedicines (2023-06-01)Get full text
Article -
6
Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease by Sylwia Wasiak, Dean Gilham, Emily Daze, Laura M. Tsujikawa, Christopher Halliday, Stephanie C. Stotz, Brooke D. Rakai, Li Fu, Ravi Jahagirdar, Michael Sweeney, Jan O. Johansson, Norman C. W. Wong, Ewelina Kulikowski
Published in Cardiovascular Therapeutics (2020-01-01)Get full text
Article -
7
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro by Dean Gilham, Audrey L. Smith, Li Fu, Dalia Y. Moore, Abenaya Muralidharan, St. Patrick M. Reid, Stephanie C. Stotz, Jan O. Johansson, Michael Sweeney, Norman C. W. Wong, Ewelina Kulikowski, Dalia El-Gamal
Published in Biomedicines (2021-04-01)Get full text
Article
